Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Assets (2016 - 2025)

Jaguar Health (JAGX) has disclosed Current Assets for 11 consecutive years, with $29.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 19.76% to $29.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $29.4 million, a 19.76% decrease, with the full-year FY2024 number at $32.2 million, up 15.15% from a year prior.
  • Current Assets was $29.4 million for Q3 2025 at Jaguar Health, up from $27.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $44.3 million in Q2 2021 to a low of $22.1 million in Q3 2023.
  • A 5-year average of $30.6 million and a median of $28.5 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: surged 544.8% in 2021, then plummeted 47.26% in 2022.
  • Jaguar Health's Current Assets stood at $28.4 million in 2021, then fell by 21.5% to $22.3 million in 2022, then rose by 25.28% to $28.0 million in 2023, then grew by 15.15% to $32.2 million in 2024, then decreased by 8.68% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Current Assets are $29.4 million (Q3 2025), $27.9 million (Q2 2025), and $30.4 million (Q1 2025).